Announced Thu, 13 Aug · 16:45 IST
Newspaper publication of Q1 FY27 unaudited financial results
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-7.5%1-day move
₹29.99
prior close
₹29.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.1-3.4-2.4-3.4-7.5-6.7-10.0-10.4-7.6+9.0+0.4+11.2——
Up moveDown movePending
AI summary
Mangalam Drugs and Organics has published its Q1 FY27 (quarter ended 30 June 2026) unaudited standalone and consolidated financial results in Financial Express and Loksatta newspapers, as required by SEBI. Board approved the results on 12 August 2026. Standalone net loss narrowed to Rs 755.36 lakh from Rs 1,372.80 lakh in Q1 FY26. Consolidated net loss stood at Rs 763.88 lakh versus Rs 1,379.83 lakh year ago. Standalone basic EPS was negative Rs 4.77.
Likely market impact
Year-on-year losses have nearly halved at both standalone and consolidated levels, indicating improvement, though the company is still loss-making.